As a strategic resource platform for precision medicine and life science research, the construction quality of a biobank directly affects the reproducibility of research results and the reliability of clinical translation. As a key component of a biobank's quality management system, identification management runs through the entire process of specimen collection, processing, storage, and distribution.
1. Industry Requirements for Biobank Identification Management
ISO 20387 "Biotechnology — Biobanking — General requirements for biobanking" sets clear specifications for specimen identification: each specimen should have a unique identifier, and the identification should be clear, durable, and traceable. The "Specifications for Construction and Management of Biobanks" issued by the China Medicinal Biotech Association also emphasizes that specimen labels should remain intact and identifiable under storage conditions.
However, in actual operations, many biobanks face identification management problems such as label detachment, illegible writing, incomplete information, and inconsistent coding, which directly affect specimen usability and data integrity.
2. BRD Standardized Identification Solution
Standardized material selection: Based on specimen storage temperature (liquid nitrogen -196 °C, -80 °C ULT freezer, -40 °C freezer) and container type (cryovial, microcentrifuge tube, microplate, cryobox), standardized label material recommendations are provided. Lab series PET-based labels are suitable for long-term liquid nitrogen storage, PP-based labels are suitable for daily use at -80 °C, and nylon cloth-based labels are suitable for irregular surfaces.
Unified information coding: Three information carriers are supported: 1D barcodes (Code 128/Code 39), 2D barcodes (QR Code/Data Matrix), and RFID chips. A unified coding rule of "project number + specimen type + collection date + serial number" is recommended to ensure full-chain traceability of specimen information.
Standardized printing process: Standard printing templates and operating SOPs are provided, including label printer parameter settings, ribbon selection (resin-based ribbon recommended), print quality self-inspection (barcode grade ≥ B), and surface cleaning specifications before label application.
3. Full Lifecycle Traceability System
From specimen accessioning, cryostorage location recording, specimen retrieval and return, to final disposal, the BRD identification solution supports full lifecycle information tracking. Combined with a LIMS laboratory information management system, automated management of specimen localization, inventory counting, and temperature control records can be achieved, meeting GLP/GCP compliance audit requirements.
4. Typical Applications
Large cohort study biobanks: Precise identification and efficient retrieval of hundreds of thousands of specimens, supporting large-scale epidemiological investigations and genomic research.
Clinical biobanks: Standardized collection and long-term preservation of clinical specimens such as tumor tissue, blood, and body fluids, meeting translational medicine research needs.
Stem cell banks: Full-process identification and traceability of stem cell preparations, compliant with cell therapy product quality management specifications.
Regional central biobanks: Specimen resource sharing platforms for multi-center collaboration, with unified identification standards enabling cross-institutional specimen recognition.
5. Implementation Recommendations
Standardized biobank identification construction is recommended to be implemented in steps: Step 1, assess existing identification problems and develop a standardization plan; Step 2, select suitable label materials and coding schemes, and complete small-batch validation; Step 3, roll out comprehensively and establish a regular review mechanism. BRD can provide sample testing, printing compatibility guidance, and on-site technical training to help biobanks quickly establish identification management standards.
To learn more about standardized biobank identification solutions or to request sample testing, please contact the BRD technical team.
Related Compliance Standards
Standardized biobank identification management establishes the identification and records system based on ISO 20387:2018 "General requirements for biobanking" and ISO 17025:2017, with label barcode quality implemented per ISO/IEC 15416.
Featured Products
For the label materials and applications covered in this article, the following BRD products are available for selection reference (click to view specifications and request a quote):
- EOS2/3生物样本库标签打印机医疗实验室低温液氮冻存管锥管离心管（Request a Quote）
- MACH4S实验室装备液氮冻存管载玻片生物样本库低温液氮标签打印机（Request a Quote）
- BBP12贝迪BRADY实验室科研机构医疗生物样本库低温液氮标签打印机（Request a Quote）
- Lab162-629/40x20样本库冻存管-196℃液氮尼龙低温标签生物样本库18015583218（¥999/roll）
FAQ
Q: What steps does standardized biobank identification management include?
It includes the full process of coding rule design, label selection, labeling specifications, scan-code entry, periodic quality spot checks, and information traceability — all interlinked.
Q: How should label coding rules be designed?
A hierarchical coding approach is recommended: biobank/project code + storage location (tank/rack/box/position) + specimen serial number, combined with 2D barcodes to provide both machine-readable and human-readable assurance.
Q: What does standardized management mean for specimen quality?
Identification standardization is the foundation of specimen traceability and directly affects the reliability of experimental data; missing or incorrect identification can lead to specimen misuse and misjudgment, and is a high-frequency point of quality incidents in biobanks.
Elements of Standardized Biobank Identification Management
The core elements of standardized biobank identification management include: unique numbering rules, label selection standards, labeling operating specifications, scan-code verification processes, and information recording and archiving. These five elements are interlinked and together form the management foundation for specimen traceability.
| Element | Key Points |
|---|---|
| Numbering rules | Unique, stable, extensible, written into SOP |
| Label selection | Resistant to target temperature, freeze–thaw resistant, barcode readable |
| Labeling specifications | Clean, press-fit, cure, scan verification |
| Information archiving | Full documentation of specimen source, processing, location, and destination |
Compliance Support for Identification Management
Biobank identification management is an important focus of ISO 20387:2018 (General requirements for biobanking), emphasizing unique specimen identity, complete information, and full traceability. In addition, specimen identification related to clinical laboratory testing must also meet the requirements of ISO 15189:2022. Standardized identification management is an important foundation for biobanks to pass accreditation review and ethical review.
From Standard to Implementation
Implementing standardized identification management requires a three-pronged approach of system + tools + training: on the system side, clearly define numbering, selection, labeling, and verification standards; on the tools side, equip matching labels, printers, and scanning systems; on the training side, ensure consistent execution by operators. Only by combining all three can "standards" be transformed from paper into reliable daily operations.
Continuous Improvement of Identification Standards
Biobank identification standards should be continuously improved as operations change: when specimen types increase, storage equipment is updated, or systems are upgraded, promptly assess label compatibility and update SOPs. Establishing a regular review mechanism allows identification management to match actual needs over the long term and avoids traceability risks caused by outdated standards.